Skip to content
Politically.com Search all
Menu

2025 · 3rd Quarter (July 1 - Sep 30)

X-BIOTIX THERAPEUTICS, INC.

Filed by INNOVATIVE FEDERAL STRATEGIES, LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 20, 2025
Income
Not reported
Expenses
Not reported
Filing UUID
fed783bc-3936-4448-8c6a-0c0e490ade6b
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

H.R.5304/S.2587, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026, Title II, all provisions related to Antimicrobial Resistance.

Literal federal measure citations: H.R.5304, S.2587

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.